These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 33179818)
1. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial. Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML; Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818 [TBL] [Abstract][Full Text] [Related]
2. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial. Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212 [TBL] [Abstract][Full Text] [Related]
3. Reexamining the Hypoglycemia Fear Survey for Parents of Young Children in a Sample of Children Using Insulin Pumps. Patton SR; Noser AE; Clements MA; Dolan LM; Powers SW Diabetes Technol Ther; 2017 Feb; 19(2):103-108. PubMed ID: 28118046 [TBL] [Abstract][Full Text] [Related]
4. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy. Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616 [TBL] [Abstract][Full Text] [Related]
5. Continuous Glucose Monitoring in Children with Type 1 Diabetes Improves Well-Being, Alleviates Worry and Fear of Hypoglycemia. Ng SM; Moore HS; Clemente MF; Pintus D; Soni A Diabetes Technol Ther; 2019 Mar; 21(3):133-137. PubMed ID: 30785768 [TBL] [Abstract][Full Text] [Related]
6. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion. Patton SR; Dolan LM; Henry R; Powers SW Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061 [TBL] [Abstract][Full Text] [Related]
7. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes. De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656 [TBL] [Abstract][Full Text] [Related]
8. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring. Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192 [No Abstract] [Full Text] [Related]
9. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study. Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O; Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902 [TBL] [Abstract][Full Text] [Related]
11. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes. Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976 [TBL] [Abstract][Full Text] [Related]
12. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. Brazg RL; Bailey TS; Garg S; Buckingham BA; Slover RH; Klonoff DC; Nguyen X; Shin J; Welsh JB; Lee SW J Diabetes Sci Technol; 2011 Nov; 5(6):1466-71. PubMed ID: 22226267 [TBL] [Abstract][Full Text] [Related]
13. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663 [TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring Decreases Hypoglycemia Avoidance Behaviors, but Not Worry in Parents of Youth With New Onset Type 1 Diabetes. Youngkin EM; Majidi S; Noser AE; Stanek KR; Clements MA; Patton SR J Diabetes Sci Technol; 2021 Sep; 15(5):1093-1097. PubMed ID: 32522029 [TBL] [Abstract][Full Text] [Related]
15. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents. Bisio A; Brown SA; McFadden R; Pajewski M; Yu PL; DeBoer M; Schoelwer MJ; Bonner HG; Wakeman CA; Cherñavvsky DR; Gonder-Frederick L Pediatr Diabetes; 2021 May; 22(3):495-502. PubMed ID: 33289242 [TBL] [Abstract][Full Text] [Related]
16. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes. Jabbour G; Bragazzi NL Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227 [TBL] [Abstract][Full Text] [Related]
18. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Pickup JC; Ford Holloway M; Samsi K Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422 [TBL] [Abstract][Full Text] [Related]
19. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics. Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ; BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216 [TBL] [Abstract][Full Text] [Related]
20. Psychological Well-Being of Parents of Very Young Children With Type 1 Diabetes - Baseline Assessment. de Beaufort C; Pit-Ten Cate IM; Schierloh U; Cohen N; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Thiele AG; Abt D; Faninger K; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; Campbell F; Rami-Merhar B; Hovorka R Front Endocrinol (Lausanne); 2021; 12():721028. PubMed ID: 34456876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]